Gwen Macdonald

Oncology · 2009

A researcher in the Science corpus: 1 paper; trusts 4 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

• Oncology — 26 citations into it; #790 of 1,698 by trust here, #1,530 by citations
• Molecular Biology — 22 citations into it; #10,533 of 17,773 by trust here, #15,531 by citations
• Radiology, Nuclear Medicine and Imaging — 15 citations into it
• Pulmonary and Respiratory Medicine — 12 citations into it; #298 of 770 by trust here, #608 by citations

Whom Gwen Macdonald trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. H. Horlings

Who trusts Gwen Macdonald overall

1. D. Hanahan
2. R. Weinberg

Papers from Gwen Macdonald's perspective

Ordered by how strongly the researchers Gwen Macdonald trusts endorse each paper. Same corpus, a different order for every researcher.

1. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. (New England Journal of Medicine)
2. Untangling the ErbB signalling network (Nature reviews. Molecular cell biology)
3. PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. (Cancer Cell)
4. Trastuzumab--mechanism of action and use in clinical practice. (New England Journal of Medicine)
5. The PIK3CA gene is mutated with high frequency in human breast cancers (Cancer Biology & Therapy)
6. Escape from HER family tyrosine kinase inhibitor therapy by the kinase inactive HER3 (Nature)
7. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab (Nature)
8. Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin). (Journal of the National Cancer Institute)
9. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. (Cancer Research)
10. High Frequency of Mutations of the PIK3CA Gene in Human Cancers (Science)

Their papers

• ErbB receptors and signaling pathways in cancer. (2009) — 969 citations